Introduction Irritable bowel syndrome (IBS), which presents a significant healthcare and socioeconomic burden, is currently one of the main issues in the field of therapy. Hence, it is imperative to tackle this matter by evaluating the safety and efficacy of the available treatments and determining the ideal approach for each patient.
No takes yet. Share an insight, caveat, or question.
Mozaffari et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: